Abstract
Metabolic or cardiometabolic syndrome (CMS) represents a complex of risk factors for cardiovascular atherosclerotic disease and for type 2 diabetes mellitus. The last, s.c. "harmonized definition" of CMS modified for the Czech population, is presented.
Cardiometabolic syndrome done by that definition is in association with 5times higher risk for type 2 diabetes and with 3times higher risk for cardiovascular diseases than in subjects without CMS. To identify patients with CMS is important especially in primary prevention of cardiovascular disease and diabetes.
The background of this syndrome lies in insulin resistance and represents residual vascular risk, which persists in up to date well-treated patients. This syndrome has become a symbol of the Czech Institute of Metabolic Syndrome (CIMS, o.p.s.) non-profit organization, which was established in the year 2008.
Some of CIMS activities are mentioned in the article.